United Therapeutics (UTHR) Gross Profit (2016 - 2025)
Historic Gross Profit for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $698.6 million.
- United Therapeutics' Gross Profit rose 492.64% to $698.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 5112.91%. This contributed to the annual value of $2.6 billion for FY2024, which is 2404.35% up from last year.
- As of Q3 2025, United Therapeutics' Gross Profit stood at $698.6 million, which was up 492.64% from $711.0 million recorded in Q2 2025.
- United Therapeutics' 5-year Gross Profit high stood at $711.0 million for Q2 2025, and its period low was -$70.0 million during Q4 2023.
- In the last 5 years, United Therapeutics' Gross Profit had a median value of $466.7 million in 2022 and averaged $490.2 million.
- In the last 5 years, United Therapeutics' Gross Profit plummeted by 11617.75% in 2023 and then soared by 3304.0% in 2024.
- Quarter analysis of 5 years shows United Therapeutics' Gross Profit stood at $380.6 million in 2021, then rose by 13.69% to $432.7 million in 2022, then crashed by 116.18% to -$70.0 million in 2023, then surged by 1051.14% to $665.8 million in 2024, then grew by 4.93% to $698.6 million in 2025.
- Its Gross Profit stands at $698.6 million for Q3 2025, versus $711.0 million for Q2 2025 and $701.9 million for Q1 2025.